Antiangiogenic and antivascular therapy for cancer.
作者： Giulia Taraboletti , Barbara Margosio
DOI: 10.1016/S1471-4892(01)00065-0
关键词: Tumor angiogenesis 、 Tumor vasculature 、 Clinical trial 、 Combined Modality Therapy 、 Pharmacology 、 Oncology 、 Medicine 、 Cancer 、 Internal medicine 、 Cancer biology
摘要: The great interest in the potential antineoplastic effect of targeting tumor-associated blood vessels has generated an expanding armamentarium therapeutic tools that include antiangiogenic compounds, aimed at preventing formation vessels, and antivascular targeted to existing tumor vasculature. Following promising preclinical studies, drugs have rapidly gained access clinical trials.
elsevier.com
sci-hub.se 参考文章(61)
Mark Nesbit, Abrogation of tumor vasculature using gene therapy. Cancer and Metastasis Reviews. ,vol. 19, pp. 45- 49 ,(2000) , 10.1023/A:1026588028780
Israel Vlodavsky, Yael Friedmann, Michael Elkin, Helena Aingorn, Ruth Atzmon, Rivka Ishai-Michaeli, Menachem Bitan, Orit Pappo, Tuvia Peretz, Israel Michal, Larissa Spector, Iris Pecker, Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nature Medicine. ,vol. 5, pp. 793- 802 ,(1999) , 10.1038/10518
Lynn Hlatky, Melvin E. Clouse, Ernest F. Terwilliger, Ping Wu, Josephine T. Nguyen, Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy. Cancer Research. ,vol. 58, pp. 5673- 5677 ,(1998)
William O’Connor, Daniel J. Hicklin, Elisabetta Dejana, Paolo Mignatti, Andrea Hooper, Yiwen Li, Angel Santiago, Lucia Zanetta, Peter Bohlen, Jay Overholser, Francesca-Fang Liao, Rajiv Bassi, Monoclonal Antibody to Vascular Endothelial-cadherin Is a Potent Inhibitor of Angiogenesis, Tumor Growth, and Metastasis Cancer Research. ,vol. 60, pp. 6805- 6810 ,(2000)
Boning Gao, Philip E. Thorpe, Neal Rote, Steve Duffy, Sophia Ran, Linda Watkins, Infarction of Solid Hodgkin's Tumors in Mice by Antibody-directed Targeting of Tissue Factor to Tumor Vasculature Cancer Research. ,vol. 58, pp. 4646- 4653 ,(1998)
Mihaela Skobe, Thomas Hawighorst, David G. Jackson, Remko Prevo, Lauren Janes, Paula Velasco, Lucia Riccardi, Kari Alitalo, Kevin Claffey, Michael Detmar, Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis Nature Medicine. ,vol. 7, pp. 192- 198 ,(2001) , 10.1038/84643
Peter Carmeliet, Rakesh K. Jain, Angiogenesis in cancer and other diseases Nature. ,vol. 407, pp. 249- 257 ,(2000) , 10.1038/35025220
R Giavazzi, V Lucchini, G Taraboletti, A Garofalo, M I Nicoletti, E A Bone, C Ferri, S Chiari, P D Brown, Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts. Clinical Cancer Research. ,vol. 4, pp. 985- 992 ,(1998)
Thomas Boehm, Judah Folkman, Timothy Browder, Michael S. O'Reilly, Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature. ,vol. 390, pp. 404- 407 ,(1997) , 10.1038/37126
H. Michael Ellerby, Wadih Arap, Lisa M. Ellerby, Renate Kain, Rebecca Andrusiak, Gabriel Del Rio, Stanislaw Krajewski, Christian R. Lombardo, Rammohan Rao, Erkki Ruoslahti, Dale E. Bredesen, Renata Pasqualini, Anti-cancer activity of targeted pro-apoptotic peptides Nature Medicine. ,vol. 5, pp. 1032- 1038 ,(1999) , 10.1038/12469